3 Material und Methoden
6.1 Literaturverzeichnis Einleitung
6 Literaturverzeichnis
6.1 Literaturverzeichnis Einleitung
1 Texte und Materialien der Bundesärztekammer zur Fortbildung und Weiterbildung 1998; Band 19,1.Auflage. „Gesundheit im Alter“, Köln, Bundesärztekammer, ISSN 0945-1951
2 www.who.int
3 Newsletter NÖ GKK, März (2009), Nr.25
4 Dissertation (2006), Greiner D, Verschreibungsverhalten von niedergelassenen Ärzten für Allge-meinmedizin bei polypragmatisch behandelten Patienten: Wechselwirkungen und Patientensicher-heit. Eberhard Karls Universität Tübingen
5 GGW 2/2006, April, 6.Jg. Kettner, M, „Wunscherfüllende Medizin“ – Assistenz zum besseren Leben?
6 Arzneimitteltherapie 23, (2005):S.176–180. Meinertz T, Kähler J, Polypharmakotherapie – Ein Problem der Evidence-based Medicine
7 Newsletter NÖ GKK, März (2009), Nr.25
8 Am J Emerg Med. 14, 1996:447-50. Goldberg RM et al, Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. PMID: 8765105
9 Allgemeine Pharmakologie und Toxikologie (2000):S.1-45. Bock KW, Klotz U, Estler CJ (Hrsg.), Schattauer, Stuttgart-New York
10 Clin Pharmacol Ther. 2001 Apr;69(4):260-65. Halkin H et al, Preventing drug interactions by online prescription screening in community pharmacies and medical practices. PMID: 11309555
11 ABDA-Datenbank, Stand 08/2004
12 Pharmazeutische Praxis (2001):S.358-78. Ammon HPT, Arzneimittelwechselwirkungen. Kovar KA (Hrsg.), Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
13 Arzneimittelwirkungen (2001):S.6. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
14 Pharmakotherapie, Klinische Pharmakologie (1997):S.460-69. Kirch W, Wechselwirkungen zwischen Arzneimittel. Fülgraff G, Palm D (Hrsg.), Gustav Fischer, Stuttgart-Jena-Lübeck-Ulm
15 Allgemeine Pharmakologie und Toxikologie (2000):S.1-45. Bock KW, Klotz U, Estler CJ (Hrsg.), Schattauer, Stuttgart-New York.
16 1. Eur J Drug Metab Pharmacokinet. 1986 Oct-Dec;11(4):249-50. Kirch W et al, Effect of cis-apride and metoclopramide on digoxin bioavailability. PMID: 3582418
17 Acta Paediatr Jpn. 1989 Feb;31(1):35-44. Funato M et al, Influence of drugs on albumin and bilirubin interaction. PMID: 2504025
18 Lancet. 1979 Aug 18;2(8138):317-19. Serlin MJ et al, Cimetidine: interaction with oral antico-agulants in man. PMID: 89387
19 Clin Pharmacokinet. 1997 Sep;33(3):184-213. Davies NM, Anderson KE, Clinical pharmacoki-netics of diclofenac.Therapeutic insights and pitfalls. PMID: 9314611
20 Pharmazeutische Zeitung (2006);Ausgabe 5. Zagermann-Muncke P, Wenn Arzneistoffe Trans-portproteine beeinflussen, Govi-Verlag, Eschborn
21 Clin Pharmacol Ther. 2000 Sep;68(3):231-37. Sadeque AJ et al,
Increased drug delivery to the brain by P-glycoprotein inhibition. PMID: 11014404
22 Clin Pharmacol Ther. 2000 Oct;68(4):345-55. Westphal K et al, Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interac-tion. PMID: 11061574
23 Obstet Gynecol. 2001 Nov;98(5 Pt 1):853-60. Dickinson BD et al, Drug interactions between oral contraceptives and antibiotics. Council on Scientific Affairs, American Medical Association.
PMID: 11704183
24 Arzneimittelforschung 2009;59(7):327-34. Srinivas NR, Antacid use and reduced bioavailability of oral drugs. Case studies, overview and perspectives. PMID: 19728559
25 Kurzlehrbuch Pharmakologie und Toxikologie (2008):S.13f. Herdegen T et al, Thieme Verlag, Stuttgart.
26 Arzneimittelwirkungen (2001):S.5ff. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
27 Arzneimittelwirkungen (2001):S.24ff. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
28 Lancet360. 2002:1155–62. Nebert DW, Russell DW, Clinical importance of the cytochromes P450. PMID: 12387968
29 Arzneimittelwirkungen (2001):S.26ff. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
30 Molecular Aspects of Medicine 1999 Feb-April;20(1-2):1-137. Hasler JA et al, Human cyto-chromes P450. PMID: 10575648
31 Indiana University School of Medicine (2007). Accessed 2/2010. Flockhart DA, Drug Interac-tions: Cytochrome P450 Drug Interaction Table http://medicine.iupui.edu/clinpharm/ddis/table.asp.
32 Drug Metab Rev. 2009;41(2):89-295. Zhou SF, Liu JP, Chowbay B, Polymorphism of human cytochrome P450 enzymes and its clinical impact. PMID: 19514967
33 Adv. Drug Deliv.Rev. 2002;54:1271–94. Lamba JK et al, Genetic contributionto variable human CYP3A-mediated metabolism. PMID: 12406645
34 Fundam. Clin. Pharmacol. 2003;17:27–41. Daly AK, Pharmacogenetics of the major polymor-phic metabolizing enzymes. PMID: 12588628
35 Molecular interventions, (6/2004);4(3):157-62. Frye RF, Probing the world of cytochrome P450 enzymes. PMID: 15210869
36 Biochem Pharmacol. 2006 May 28;71(11):1531-39. Epub 2006 Feb 7. Miners JO et al, In vitro-in vivo correlation for drugs and other compounds elimvitro-inated by glucuronidation vitro-in humans: pitfalls and promises. PMID: 16455060
37 Arzneimittelwirkungen (2001):S.31. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
38 Drug Metab Dispos. 2009 Jan;37(1):32-40. Epub 2008 Oct 6. Ohno S, Nakajin S,
Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction.
PMID: 18838504
39 Drug Metab Rev. 2010;42(1):202-17. Court MH, Interindividual variability in hepatic drug glu-curonidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. PMID: 19821798
40 Arzneimittelwirkungen (2001):S.251. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
41 Curr Drug Metab. 2007 Dec;8(8):839-51. Preziosi P, Isoniazid: metabolic aspects and toxicolo-gical correlates. PMID: 18220565
42 Tuberk Toraks. 2008;56(1):81-86. Bozok Cetintaș V et al, Determining the relation between N-acetyltransferase-2 acetylator phenotype and antituberculosis drug induced hepatitis by molecular biologic tests. PMID: 18330759
43 Arzneimittelwirkungen (2001):S.10ff. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
44 FASEB J. 1987;1: 51-54. Cornwell MM et al, ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells. PMID: 2886389
45 Biochim Biophys Acta. 1976 Nov 11;455(1):152-62. Juliano RL, Ling V, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. PMID: 990323
46 Science. 1983 Sep 23;221(4617):1285-88. Kartner N, Riordan JR, Ling V, Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. PMID: 6137059
47 Cell 1987 Nov 7;47:381-89. Chen CJ et al, Internal Duplication and Homology with Bacterial Transport Proteins in the mdr1 (P-Glycoprotein) Gene from Multidrug-Resistant Human Cells.
PMID: 2876781
48 FASEB J. 1987;1: 51-54. Cornwell MM et al, ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells. PMID: 2886389
49 Pharmazeutische Zeitung, Ausgabe 50/(2006). Zagermann-Muncke P, Wenn Arzneistoffe Trans-portproteine beeinflussen. 2010 Govi-Verlag, Eschborn
50 1. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7661-65. Fojo AT et al, Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. PMID: 3865187
51 J Biol Chem. 1986 Jun 15;261(17):7762-70. Shen DW et al, Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vin-blastine show changes in expression of specific proteins. PMID: 3711108
52 Breast Cancer Research and Treatment 1987; 9:5-16. Fojo AT et al, Molecular biology of drug resistance. PMID: 3297213
53 Hum Gene 1987;77:142-44. Callen DF et al, Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. PMID: 3477522
Cancer Genet Cytogenet. 1987;25:141-48. Bell DR et al, Chromosomal Location of Human P-Glycoprotein Gene Sequences. PMID: 2879621
54 PNAS 2000 March 28;97(7):3473-78. Hoffmeyer S et al, Functional polymorphisms of the hu-man multidrug resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. PMID: 10716719
55 Proc. Natl. Acad. Sci. USA 1987 Nov;84:7735-38. Thiebaut F et al, Cellular localisation of the multidrug-resistence gene product P-glycoprotein in the normal human tissues. PMID: 2444983
56 Dialogues Clin Neurosci. 2006;8(3):311-21. Girardin F, Membrane transporter proteins: a chal-lenge for CNS drug development. PMID: 17117613
57 Arzneimittelwirkungen (2001):S13. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
58 Arzneimittelwirkungen (2001):S.132. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
59 Kurzlehrbuch Pharmakologie und Toxikologie (2008):S.30f. Herdegen T, Thieme Verlag, Stutt-gart, New York.
60 Data Assessment in Pharmacovigilance. Meyboom RHB
61 www.amuep-agate.de, www.medbo.de/267.0.html
62 Prog Neuropsychopharmacol Biol Psychiatry 2009 Oct 1;33(7):1167-72. Epub 2009 Jun 26. Lin E et al, Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. PMID: 19560507
63 Kurzlehrbuch Pharmakologie und Toxikologie (2008):S.500. Herdegen T, Thieme Verlag, Stutt-gart, New York.
64 Arzneimittelwirkungen (2001):S.56. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
65 Arzneimittelwirkungen (2001):S.183f. Mutschler E, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart